We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




POC Test Identifies and Differentiates Viral from Bacterial Acute Respiratory Infection in 10 Minutes

By LabMedica International staff writers
Posted on 22 Jun 2022

Clinical diagnosis of patients with viral and bacterial acute respiratory infection can be a challenge due to similar signs and symptoms. More...

An acute respiratory infection, typically presenting as cough, cold, sore throat, and runny nose, is the most common single reason for visiting a doctor and antibiotic prescriptions. However, most coughs, colds, sore throats, runny noses and earaches are caused by viruses and do not require antibiotics. Accurate detection of a viral infection can help prioritize which patients should have pathogen-specific testing performed. Now, a rapid test to differentiate a viral from a bacterial infection may lead to a considerable reduction in unnecessary antibiotics, which could lead to a reduction in antimicrobial resistance and adverse events.

FebriDx from Lumos Diagnostics (Melbourne, Australia) is a rapid, all-in-one point-of-care test device that can differentiate a viral from bacterial acute respiratory infection. FebriDx can be used to help in decision making at the point of care to reduce uncertainty, avoid unnecessary antibiotics, and enable appropriate patient management. It can assist with a diagnosis in 10 minutes for patients with acute respiratory infections. The FebriDx test is easily performed by a nurse or healthcare worker to help with decision making and freeing up valuable physician time. FebriDx can aid in determining whether a patient needs antibiotics within a single clinic visit.

In multi-center U.S. clinical trials to evaluate the diagnostic accuracy of FebriDx in distinguishing between bacterial and viral acute respiratory infections, the test was determined to have both high sensitivity (up to 95%) to detect a bacterial infection and up to 99% negative predictive value (NPV) to safely rule out a bacterial infection. Additionally, an economic evaluation has concluded that using the FebriDx test to guide antibiotic treatment for patients presenting with acute respiratory infections could potentially result in USD 2.5 billion of annual cost saving for the U.S. healthcare system.

Related Links:
Lumos Diagnostics 


Gold Member
Respiratory Syncytial Virus Test
OSOM® RSV Test
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Sperm Quality Analyis Kit
QwikCheck Beads Precision and Linearity Kit
Automated Chemiluminescence Immunoassay Analyzer
MS-i3080
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Industry experts gather at WHX Labs Dubai to discuss how leadership must adapt as AI and automation transform the laboratory (Photo courtesy of Shutterstock)

WHX Labs in Dubai spotlights leadership skills shaping next-generation laboratories

WHX Labs in Dubai (formerly Medlab Middle East), held at Dubai World Trade Centre (DWTC) from 10–13 February, brings together international experts to discuss the factors redefining laboratory leadership,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.